Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2013
10/10/2013WO2013151662A2 Therapies, vaccines, and predictive methods for infectious salmon anemia virus
10/10/2013WO2013151649A1 Glycan-interacting compounds
10/10/2013WO2013151627A1 Methods of treating glucose metabolism disorders
10/10/2013WO2013151595A1 Improved adjuvant system for oral vaccine adminstration
10/10/2013WO2013151567A1 Equine encephalitis virus vaccines and methods of using thereof
10/10/2013WO2013150623A1 Conjugate of anti-cdh3 (p-cadherin) antibody and drug
10/10/2013WO2013150518A1 Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
10/10/2013WO2013150309A1 Clostridium difficile antigens
10/10/2013WO2013150284A1 Tolerisation- inducing composition
10/10/2013WO2013150142A1 Method for the preparation of a strain- adapted vaccine
10/10/2013WO2013150138A1 Secretory immunoglobulin complex
10/10/2013WO2013150043A1 Bispecific antibodies against human tweak and human il17 and uses thereof
10/10/2013WO2013149974A1 Peptide vaccines for the prevention of foot-and-mouth disease
10/10/2013WO2013149526A1 Multi-functional antibody polypeptide for cryptic epitope of epidermal growth factor receptor and t cell antigen
10/10/2013WO2013149422A1 Method for preparing freeze-dried b-type haemophilus influenza conjugate vaccine
10/10/2013WO2013149334A1 Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines
10/10/2013WO2013149306A1 Antibodies to htra3
10/10/2013WO2013121441A3 Synthetic peptides capable of binding to influenza hemagglutinin protein
10/10/2013WO2013097022A3 Recombinant proteins, polynucleotides and vaccines to combat bovine herpesvirus
10/10/2013WO2013093919A3 A combination therapy for a stable and long term engraftment using specific protocols for t/b cell depletion
10/10/2013WO2013091040A3 Brucella ovis attenuated strain, vaccine composition and use
10/10/2013WO2013090644A3 Anti-hiv antibodies having increased potency and breadth
10/10/2013WO2013084000A3 Exosomes for delivery of biotherapeutics
10/10/2013WO2013066879A3 SOLUBLE UROKINASE RECEPTOR (suPAR) IN DIABETIC KIDNEY DISEASE
10/10/2013WO2013056148A3 Scd1 antagonists for treating cancer
10/10/2013WO2012107747A8 Antigenic gly1 polypeptides
10/10/2013US20130267028 Recombinant Influenza Viruses for Vaccines and Gene Therapy
10/10/2013US20130266635 Phospholipid drug analogs
10/10/2013US20130266614 Lipid carrier for delivery of bioactive substance and pharmaceutical composition
10/10/2013US20130266613 Outer membrane proteins of histophilus somni and methods thereof
10/10/2013US20130266612 Vaccine composition
10/10/2013US20130266611 Recombinant viral vectors
10/10/2013US20130266610 Stimulating anti-tumor immune response and boosting cancer immunotherapy via expression of 15-pgdh
10/10/2013US20130266609 Vaccine composition
10/10/2013US20130266608 Methods and compositions to produce vaccines against smallpox in plants
10/10/2013US20130266607 Cholera Toxin Chimera and its Use as a Staph Vaccine
10/10/2013US20130266603 PCV/Mycoplasma Hyopneumoniae/PRRS Combination Vaccine
10/10/2013US20130266602 PCV/Mycoplasma Hyopneumoniae Combination Vaccine
10/10/2013US20130266601 Mycoplasma Hyopneumoniae Vaccine
10/10/2013US20130266600 Functional Mutations In Respiratory Syncytial Virus
10/10/2013US20130266598 Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For Immunotherapy
10/10/2013US20130266597 Small Cationic Antimicrobial Peptides
10/10/2013US20130266593 Microvesicle protein for cancer targeting
10/10/2013US20130266591 Use of tri-substituted glycerol compounds for the treatment of hematological malignancies
10/10/2013US20130266588 Agents, Compositions, And Methods For Treating Pruritis And Related Skin Conditions
10/10/2013US20130266586 Method of Providing Disease-Specific Binding Molecules and Targets
10/10/2013US20130266585 Method of Providing Disease-Specific Binding Molecules and Targets
10/10/2013US20130266583 Clostridium difficile antigens
10/10/2013US20130266582 Compositions and methods for treating cancer and neurodegenerative diseases
10/10/2013US20130266577 Use of a cd28 binding substance for making a pharmaceutical composition
10/10/2013US20130266576 Therapeutic factor viii antibodies
10/10/2013US20130266575 OprF/I AGENTS AND USE THEREOF IN HOSPITALIZED AND OTHER PATIENTS
10/10/2013US20130266574 Human antibodies to human angiopoietin-like protein 4
10/10/2013US20130266573 Specific binding proteins and uses thereof
10/10/2013US20130266572 Nucleic acids targeting tctp for use in the treatment of chemo-or hormone- resistant cancers
10/10/2013US20130266570 Targeting Intracellular Target-binding Determinants with Intracellular Antibodies
10/10/2013US20130266569 Compositions and methods for diagnosing and treating cancer
10/10/2013US20130266560 Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
10/10/2013US20130266559 Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
10/10/2013US20130266557 Methods for treatment of a sarcoma using an epimetabolic shifter (coenzyme q10)
10/10/2013US20130266553 Albumin Fusion Proteins
10/10/2013US20130266514 Method of Providing Disease-Specific Binding Molecules and Targets
10/10/2013US20130266510 Compositions and methods for treatment of drug resistant multiple myeloma
10/09/2013EP2647707A1 Cytotoxicity-inducing therapeutic agent
10/09/2013EP2647706A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
10/09/2013EP2647645A1 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom
10/09/2013EP2647390A1 Peptide vaccines for the prevention of foot-and-mouth disease
10/09/2013EP2647388A1 Antibodies Against ERBB3 and Uses Thereof
10/09/2013EP2647387A1 Vaccine Composition
10/09/2013EP2646567A1 Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
10/09/2013EP2646546A1 Tomm34 peptides and vaccines including the same
10/09/2013EP2646472A1 Covalently dimerized bivalent binding agents
10/09/2013EP2646471A2 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
10/09/2013EP2646470A1 Low affinity blood brain barrier receptor antibodies and uses therefor
10/09/2013EP2646468A2 Anti-ngf compositions and use thereof
10/09/2013EP2646460A1 Hypoallergenic polypeptides for the treatment of house dust mite allergy
10/09/2013EP2646459A1 Peptide scaffold design
10/09/2013EP2646055A2 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
10/09/2013EP2646054A1 Methods for treating a tumor using an antibody that specifically binds grp94
10/09/2013EP2646053A2 Compositions and methods for treating amyloid plaque associated symptoms
10/09/2013EP2646052A2 Lyophilized viral formulations
10/09/2013EP2646051A2 Liquid viral formulations
10/09/2013EP2646050A1 Vaccine against influenza h5n1 viruses, medicament and treatment of h5n1 viral infections
10/09/2013EP2646049A1 Composition for immunization against streptococcus pneumoniae
10/09/2013EP2646048A2 Stable helical ionic polypeptides
10/09/2013EP2583688A9 Multi-CBV vaccine for preventing or treating type 1 diabetes
10/09/2013EP2359854B1 Pharmaceutical compositions and methods useful for modulating angiogenesis
10/09/2013EP2261378B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class i membrane fusogenic envelope proteins
10/09/2013EP2101780B1 Methods of treating chronic inflammatory diseases using a gm-csf antagonist
10/09/2013CN103348007A Virus like particle production in plant
10/09/2013CN103347898A Combination therapy including tumor associated antigen binding antibodies
10/09/2013CN103347897A Anti-mesothelin antibodies and immunoconjugates
10/09/2013CN103347895A Polypeptides that bind to human complement component C5
10/09/2013CN103347894A Anti-GD2 antibodies
10/09/2013CN103347892A Monomeric and multimeric immunogenic peptides
10/09/2013CN103347540A Anti-alpha-v integrin antibody for the treatment of prostate cancer
10/09/2013CN103347539A Methods for treating systemic lupus erythematosus using HIV protease inhibitors
10/09/2013CN103347538A Novel modulator and method of use
10/09/2013CN103347537A Anti-folate receptor alpha antibody glycoforms
10/09/2013CN103347536A Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 1823